Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Clinical trial NCT00724997 · COMPLETED

Trial details

NCT number: NCT00724997
Sponsor: AVIR Green Hills Biotechnology AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Seasonal Human Influenza

Start date: 2007-03-01
Primary completion: 2008-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.